U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced on September 22, 2025, that the FDA is approving Leucovorin—a simple, affordable form of vitamin B9 (folate)—as a treatment option for certain symptoms of autism spectrum disorder (ASD).
This move, shared during a White House press conference alongside President Donald Trump, aims to address the rising tide of autism diagnoses by offering a targeted therapy for speech delays and communication challenges.
“For too long, families have been left without answers or options as autism rates have soared,” Kennedy said. “Today, we are taking bold action—opening the door to the first FDA-recognized treatment pathway.”
The announcement highlights leucovorin’s potential to help kids with brain folate shortages, a common issue in some autism cases.
Early studies show it can make a real difference in how children connect and express themselves.
The Growing Challenge of Autism.
Autism spectrum disorder affects how people interact, learn, and behave, often showing up in early childhood.
It’s a “spectrum” because symptoms range from mild to severe, but it can mean lifelong support needs for many.
Recent data paints a stark picture. According to the CDC’s 2025 Autism and Developmental Disabilities Monitoring Network report, about 1 in 31 U.S. children—roughly 3.2%—now live with autism, up from 1 in 36 just two years ago and nearly 400% higher than in 2000.
Boys face higher odds, with rates 3.4 times those of girls, and prevalence is even steeper in some groups: 1 in 20 boys in California.
These numbers reflect better screening but also point to possible environmental factors, fueling urgent calls for new solutions.
Why now? Kennedy’s push ties into broader efforts to probe causes like prenatal exposures, while prioritizing accessible treatments.
The FDA’s label update for leucovorin, published that same day, lets doctors prescribe it for cerebral folate deficiency (CFD)—a brain-specific folate gap linked to autism symptoms in up to 76% of cases.
Medicaid will cover it too, making it reachable for many families.
What Exactly Is Leucovorin? A Breakdown
Leucovorin, also called folinic acid, is a ready-to-use version of folate (vitamin B9), a key nutrient for brain growth, DNA repair, and nerve signaling.
Unlike regular folic acid from supplements or fortified foods, leucovorin skips a conversion step in the body, making it easier for the brain to absorb.
What’s in it? It’s typically sold as calcium folinate tablets, injections, or oral solutions. A standard dose for autism might be 0.5–2 mg per kg of body weight daily (up to 50 mg max), taken by mouth.
Why might it help autism? Some kids with autism have “cerebral folate deficiency,” where folate can’t cross into the brain due to blocked receptors—often from autoantibodies that gum up the works.
This starves brain cells of folate, worsening speech delays, irritability, and social struggles.
Leucovorin bypasses the blockage via a backup pathway (the reduced folate carrier), flooding the brain with what it needs to support language and behavior.
Promising Case Studies: Real Kids, Real Progress
Early research backs the buzz. In one open-label study of 48 children with autism and folate issues, high-dose leucovorin (2 mg/kg/day) led to big gains: verbal kids gained an average of 5.7 new words, while nonverbal ones started using 3–4 word phrases after 4 months.
Parents reported calmer moods and better eye contact too.
An example comes from 8-year-old Nathaniel Schumann in a clinical trial. Before leucovorin, he was nonverbal, relying on gestures.
Just two weeks in, he began speaking full sentences—a breakthrough that stunned his family.
In a 2024 randomized trial from India with 80 kids aged 2–10, those on leucovorin saw Childhood Autism Rating Scale (CARS) scores drop by 1.2 points more than placebo after 24 weeks—translating to milder symptoms like improved social skills and fewer repetitive behaviors.
A French pilot with 19 kids echoed this: ADOS scores (measuring core autism traits) improved by 2.8 points on average versus zero in the placebo group. Gains were strongest in younger kids (under 6) and those with confirmed folate transport problems.
These aren’t cures—autism is complex—but they show leucovorin can unlock communication for a key subset.
Beyond Folate: Other Nutrient Gaps Common in Autism
Kids with autism often face picky eating, gut troubles, or absorption issues, leading to widespread shortages.
Besides folate, common deficiencies include:
- Vitamin D: Low in up to 80% of cases; linked to weak bones, mood dips, and worse social skills.
- Vitamin B12: Affects nerve health; tied to fatigue and brain fog.
- Iron (and ferritin): Causes anemia and focus problems; consistently lower in autism kids.
- Zinc: Supports immunity and growth; shortages worsen sensory sensitivities.
- Vitamins A, C, E, and B6: Fuel brain function; gaps from restricted diets can amp up irritability.
These aren’t universal, but testing (via blood or hair) can spot them. A balanced diet helps, but supplements under doctor guidance often fill the voids.
Is Leucovorin Safe? Side Effects to Know
Leucovorin is generally well-tolerated, especially at autism doses—it’s been used safely for decades in cancer care. Most kids experience no major issues, but watch for:
- Mild: Nausea, vomiting, or fussiness (rare, under 5% in trials).
- Rare: Allergic reactions (hives, swelling), sleep changes, or fever.
- Caution: It might boost seizure risk in epilepsy-prone kids or interact with seizure meds/antibiotics like Bactrim.
It’s recommended to start low, monitor with blood tests, and pair with other therapies like speech or ABA.
Who Stands to Benefit Most—and What It’s Already Used For
Leucovorin shines for the 15–76% of autistic kids with folate receptor issues or CFD, especially those struggling with speech (nonverbal or delayed).
Younger children (under 6) and those with milder symptoms see the best results. It’s a add-on, not standalone—combine with speech therapy for max impact.
Right now, it’s FDA-approved to rescue patients from methotrexate chemo side effects, treat colorectal cancer (with 5-FU), and fix severe folate shortages causing anemia.
Off-label, it’s helped folate-related seizures or toxicities. At $10–50/month, it’s budget-friendly and generic.
More Key Facts: The Bigger Picture on Leucovorin and Autism
This approval isn’t isolated—it’s part of a $100 million HHS push for autism research, including NIH trials on leucovorin’s safety and Tylenol’s pregnancy links (debated, but flagged for caution).
Experts like Dr. Richard Frye, a pediatric neurologist, call it “a substantial impact for a good percentage of children,” though not universal.
Skeptics note small study sizes (40–80 kids) and call for bigger trials, but the low risk makes it worth trying for eligible families. Genetic tests for folate issues can guide who qualifies.
Leucovorin’s story is a nutrient turning into a tool among tough hurdles.
Talk to your doctor—testing for CFD could be your next step toward brighter connections.
Leave a Reply